{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:49:04Z","timestamp":1792162144067,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2007901"],"award-info":[{"award-number":["GNT2007901"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Glob. Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The World Health Organization recommends human papillomavirus (HPV) testing and same-day treatment for cervical screening among women in the general population in low- and middle-income countries (LMIC). Among women living with HIV, additional triage is recommended due to lower specificity and predictive value of HPV testing alone in this population. We evaluated the performance of HPV DNA testing alone and in combination with alternative triage strategies for the early detection and treatment of cervical pre-cancer among women living with HIV in Papua New Guinea (PNG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We did a prospective clinical cohort study among women living with HIV aged 30-59 years attending an HIV treatment and care service. Eligible women self-collected a vaginal specimen for point-of-care HPV DNA testing on the GeneXpert platform. All women testing HPV-positive, and a random sample of HPV-negative women, had enhanced visualisation of the cervix with digital colposcopy (EVA) and provided a clinician-collected cervical specimen for off-site liquid-based cytology. The primary outcome was the clinical performance (sensitivity, specificity, positive and negative predictive value [PPV, NPV]) of HPV testing alone and in combination with alternative triage strategies (EVA, HPV type restriction, modified assay cut-off values) for detection of high-grade squamous intraepithelial lesion (HSIL) or worse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between May 3, 2024 and December 12, 2024, we recruited 404 women, of whom 168 (41.6%) tested positive for one or more of 14 oncogenic HPV types. Estimated sensitivity and NPV for HSIL or worse using manufacturer-defined cycle threshold cutoffs was &gt;99%, specificity 63.3% (95%CI: 58.3%-68.3%), and PPV 18.6% (12.6%-24.6%). Restricting screen-positive to one or more of the 8 HPV types of greatest oncogenic potential had comparable sensitivity and NPV (&gt;99%), with specificity 70.2% (65.5%-74.9%) and PPV 22.6% (15.6%-29.6%). HPV 8-type restriction with more stringent assay cut-offs (cycle threshold &lt;33.99) had sensitivity 86.5% (75.3%-97.7%), specificity 80.1% (75.9%-84.3%), PPV 30.7% (21.7%-39.7%), and NPV 98.4% (96.9%-99.9%). EVA provided no additional benefits to HPV testing alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Applying HPV 8-type restriction with or without modified manufacturer assay cut-off values to the WHO pre-qualified Xpert HPV test improved clinical performance for detection of HSIL or worse among women living with HIV in PNG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s44263-026-00336-0","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:20:46Z","timestamp":1792160446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HPV DNA testing and treatment strategies for cervical pre-cancer among women living with HIV in Papua New Guinea: a prospective clinical cohort study"],"prefix":"10.1186","volume":"4","author":[{"given":"Joyce","family":"Sauk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela A","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Tongela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredah","family":"Koluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari","family":"Lialu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Elijah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Gabuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Ripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J","family":"Toliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heni","family":"Meke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G","family":"Badman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Kelly-Hanku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew JB","family":"Vallely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"3","key":"336_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"336_CR2","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"336_CR3","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","volume":"9","author":"D Stelzle","year":"2021","unstructured":"Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021;9(2):e161\u20139.","journal-title":"Lancet Glob Health"},{"key":"336_CR4","doi-asserted-by":"crossref","unstructured":"Dalal S, Sundstr\u00f6m K, Silva R et al. Age-specific distribution of cervical precancer and cancer among women living with HIV across seven countries: a systematic review and an individual patient data meta-analysis. Lancet HIV 2025.","DOI":"10.1016\/S2352-3018(25)00198-5"},{"issue":"12","key":"336_CR5","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1038\/s41591-023-02601-3","volume":"29","author":"MT Hall","year":"2023","unstructured":"Hall MT, Simms KT, Murray JM, et al. Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV. Nat Med. 2023;29(12):3059\u201366.","journal-title":"Nat Med"},{"key":"336_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pvr.2018.10.009","volume":"6","author":"PJ Toliman","year":"2018","unstructured":"Toliman PJ, Kaldor JM, Badman SG, et al. Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea. Papillomavirus Res. 2018;6:70\u20136.","journal-title":"Papillomavirus Res"},{"key":"336_CR7","unstructured":"UNAIDS. National HIV crisis declared in Papua New Guinea. 26. June 2025. https:\/\/unaids-ap.org\/2025\/06\/26\/national-hiv-crisis-declared-in-papua-new-guinea\/ (accessed 27 June 2025)."},{"key":"336_CR8","unstructured":"DFAT. Australia expands support for HIV services in Papua New Guinea. 13. October 2025. https:\/\/www.foreignminister.gov.au\/minister\/penny-wong\/media-release\/australia-expands-support-hiv-services-papua-new-guinea (accessed 15 October 2025)."},{"issue":"7","key":"336_CR9","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1128\/JCM.00529-16","volume":"54","author":"P Toliman","year":"2016","unstructured":"Toliman P, Badman SG, Gabuzzi J, et al. Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens. J Clin Microbiol. 2016;54(7):1734\u20137.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"336_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/13697137.2018.1439917","volume":"21","author":"PJ Toliman","year":"2018","unstructured":"Toliman PJ, Kaldor JM, Tabrizi SN, Vallely AJ. Innovative approaches to cervical cancer screening in low- and middle-income countries. Climacteric: J Int Menopause Soc. 2018;21(3):235\u20138.","journal-title":"Climacteric: J Int Menopause Soc"},{"issue":"9","key":"336_CR11","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(19)30414-0","volume":"20","author":"A Ekeroma","year":"2019","unstructured":"Ekeroma A, Dyer R, Palafox N, et al. Cancer management in the Pacific region: a report on innovation and good practice. Lancet Oncol. 2019;20(9):e493\u2013502.","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"336_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S2055-6640(20)30062-5","volume":"5","author":"A Vallely","year":"2019","unstructured":"Vallely A, Tollman P. Health service delivery models for scaling use of point-of-care HPV \u2018test and treat\u2019 strategies in high-burden, low-income settings. J Virus Eradication. 2019;5(Suppl 1):1\u20133.","journal-title":"J virus eradication"},{"issue":"4","key":"336_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.cmi.2018.05.025","volume":"25","author":"PJ Toliman","year":"2019","unstructured":"Toliman PJ, Kaldor JM, Badman SG, et al. Evaluation of self-collected vaginal specimens for the detection of high-risk human papillomavirus infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting. Clin Microbiol Infect. 2019;25(4):496\u2013503.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"336_CR14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.cmi.2019.10.020","volume":"26","author":"PJ Toliman","year":"2020","unstructured":"Toliman PJ, Phillips S, de Jong S, et al. Evaluation of p16\/Ki-67 dual-stain cytology performed on self-collected vaginal and clinician-collected cervical specimens for the detection of cervical pre-cancer. Clin Microbiol Infect. 2020;26(6):748\u201352.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"336_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.pathol.2020.10.006","volume":"53","author":"SG Badman","year":"2021","unstructured":"Badman SG, Vallely AJ, Pardo C, et al. A comparison of ThinPrep against four non-volatile transport media for HPV testing at or near the point of care. Pathology. 2021;53(2):264\u20136.","journal-title":"Pathology"},{"issue":"9","key":"336_CR16","doi-asserted-by":"publisher","first-page":"e1336","DOI":"10.1016\/S2214-109X(22)00271-6","volume":"10","author":"AJ Vallely","year":"2022","unstructured":"Vallely AJ, Saville M, Badman SG, et al. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT). Lancet Global Health. 2022;10(9):e1336\u201346.","journal-title":"Lancet Global Health"},{"issue":"1","key":"336_CR17","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1186\/s12913-022-08842-1","volume":"22","author":"H Camara","year":"2022","unstructured":"Camara H, Nosi S, Munnull G, et al. Women\u2019s acceptability of a self-collect HPV same-day screen-and-treat program in a high burden setting in the Pacific. BMC Health Serv Res. 2022;22(1):1514.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"336_CR18","doi-asserted-by":"publisher","first-page":"e007380","DOI":"10.1136\/bmjgh-2021-007380","volume":"7","author":"DTN Nguyen","year":"2022","unstructured":"Nguyen DTN, Simms KT, Keane A, et al. Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea. BMJ Global Health. 2022;7(3):e007380.","journal-title":"BMJ global health"},{"key":"336_CR19","volume-title":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition","author":"WHO","year":"2021","unstructured":"WHO. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization; 2021."},{"key":"336_CR20","volume-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem","author":"WHO","year":"2020","unstructured":"WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020."},{"key":"336_CR21","volume-title":"Strategic framework for the comprehensive prevention and control of cervical cancer in the Western Pacific Region 2023\u20132030","author":"WPRO","year":"2023","unstructured":"WPRO. Strategic framework for the comprehensive prevention and control of cervical cancer in the Western Pacific Region 2023\u20132030. Manila: World Health Organization Regional Office for the Western Pacific; 2023."},{"key":"336_CR22","volume-title":"Screening and treatment of precancerous lesions for secondary prevention of cervical cancer","author":"Unitaid","year":"2024","unstructured":"Unitaid. Screening and treatment of precancerous lesions for secondary prevention of cervical cancer. Geneva: Unitaid; 2024."},{"key":"336_CR23","unstructured":"UNSW. Record $25.9 million donation to advance cervical cancer elimination in the Pacific. 2024. https:\/\/www.kirby.unsw.edu.au\/news\/record-donation-awarded-to-kirby-from-swire"},{"issue":"2","key":"336_CR24","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1016\/S2214-109X(19)30527-3","volume":"8","author":"L Kuhn","year":"2020","unstructured":"Kuhn L, Saidu R, Boa R, et al. Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study. Lancet Glob Health. 2020;8(2):e296\u2013304.","journal-title":"Lancet Glob Health"},{"key":"336_CR25","doi-asserted-by":"publisher","first-page":"101645","DOI":"10.1016\/j.eclinm.2022.101645","volume":"53","author":"H Kelly","year":"2022","unstructured":"Kelly H, Jaafar I, Chung M, et al. Diagnostic accuracy of cervical cancer screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+\/CIN3+) among women living with HIV: A systematic review and meta-analysis. eClinicalMedicine. 2022;53:101645.","journal-title":"EClinicalMedicine"},{"issue":"6","key":"336_CR26","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1016\/S2352-3018(23)00082-6","volume":"10","author":"K Sharma","year":"2023","unstructured":"Sharma K, Machalek DA, Toh ZQ, et al. No woman left behind: achieving cervical cancer elimination among women living with HIV. Lancet HIV. 2023;10(6):e412\u201320.","journal-title":"Lancet HIV"},{"issue":"1","key":"336_CR27","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/s41467-025-56926-3","volume":"16","author":"S Joshi","year":"2025","unstructured":"Joshi S, Muwonge R, Bhosale R, et al. A randomised controlled non-inferiority trial to compare the efficacy of \u2018HPV screen, triage and treat\u2019 with \u2018HPV screen and treat\u2019 approach for cervical cancer prevention among women living with HIV. Nat Commun. 2025;16(1):1888.","journal-title":"Nat Commun"},{"issue":"1","key":"336_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12935-023-03011-8","volume":"23","author":"A Farhadi","year":"2023","unstructured":"Farhadi A, Abuei H, Okhovat MA, et al. Type distribution of human papillomaviruses in ThinPrep cytology samples and HPV16\/18 E6 gene variations in FFPE cervical cancer specimens in Fars province, Iran. Cancer Cell Int. 2023;23(1):166.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"336_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1159\/000525340","volume":"66","author":"R Gupta","year":"2022","unstructured":"Gupta R, Hussain S, Hariprasad R, et al. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group. Acta Cytol. 2022;66(6):496\u2013506.","journal-title":"Acta Cytol"},{"key":"336_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13027-020-00311-w","volume":"15","author":"PE Castle","year":"2020","unstructured":"Castle PE, Ajeh R, Dzudie A, et al. A comparison of screening tests for detection of high-grade cervical abnormalities in women living with HIV from Cameroon. Infect Agent Cancer. 2020;15:45.","journal-title":"Infect Agent Cancer"},{"issue":"3","key":"336_CR31","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/ijc.35190","volume":"156","author":"P Debeaudrap","year":"2025","unstructured":"Debeaudrap P, Kabore FN, Setha L, et al. Performance of visual inspection, partial genotyping, and their combination for the triage of women living with HIV who are screen positive for human papillomavirus: Results from the AIMA-CC ANRS 12375 multicentric screening study. Int J Cancer. 2025;156(3):598\u2013607.","journal-title":"Int J Cancer"},{"issue":"6","key":"336_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","volume":"32","author":"G Liu","year":"2018","unstructured":"Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. AIDS. 2018;32(6):795\u2013808.","journal-title":"AIDS"},{"issue":"1","key":"336_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ygyno.2017.11.002","volume":"148","author":"P Cholli","year":"2018","unstructured":"Cholli P, Bradford L, Manga S, et al. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up. Gynecol Oncol. 2018;148(1):118\u201325.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"336_CR34","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S2352-3018(17)30149-2","volume":"5","author":"H Kelly","year":"2018","unstructured":"Kelly H, Weiss HA, Benavente Y, de Sanjose S, Mayaud P. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 2018;5(1):e45\u201358.","journal-title":"Lancet HIV"},{"key":"336_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pvr.2016.02.004","volume":"2","author":"ZZA Mbulawa","year":"2016","unstructured":"Mbulawa ZZA, Wilkin TJ, Goeieman B, et al. Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women. Papillomavirus Res. 2016;2:56\u201360.","journal-title":"Papillomavirus Res"},{"issue":"1","key":"336_CR36","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s12885-017-3682-x","volume":"17","author":"D Obiri-Yeboah","year":"2017","unstructured":"Obiri-Yeboah D, Akakpo PK, Mutocheluh M, et al. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women. BMC Cancer. 2017;17(1):688.","journal-title":"BMC Cancer"},{"issue":"2","key":"336_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/QAD.0000000000001301","volume":"31","author":"HA Kelly","year":"2017","unstructured":"Kelly HA, Sawadogo B, Chikandiwa A, et al. Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV\/AIDS: effect of anti-retroviral therapy. AIDS. 2017;31(2):273\u201385.","journal-title":"AIDS"},{"issue":"2","key":"336_CR38","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ijgo.15225","volume":"165","author":"R Luckett","year":"2024","unstructured":"Luckett R, Ramogola-Masire D, Gompers A, et al. Triage of HPV positivity in a high HIV prevalence setting: A prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana. Int J Gynaecol Obstet. 2024;165(2):507\u201318.","journal-title":"Int J Gynaecol Obstet"},{"key":"336_CR39","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1200\/GO.21.00013","volume":"7","author":"C Mungo","year":"2021","unstructured":"Mungo C, Osongo CO, Ambaka J, et al. Feasibility and Acceptability of Smartphone-Based Cervical Cancer Screening Among HIV-Positive Women in Western Kenya. JCO Glob Oncol. 2021;7:686\u201393.","journal-title":"JCO Glob Oncol"},{"issue":"1","key":"336_CR40","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1016\/S2214-109X(25)00352-3","volume":"14","author":"H Phiri","year":"2026","unstructured":"Phiri H, Uwinkindi F, Diop M, et al. Performance of an artificial intelligence-based tool for cervical precancer screening in five countries in Africa: a prospective, observational, diagnostic accuracy study. Lancet Global Health. 2026;14(1):e49\u201360.","journal-title":"Lancet Global Health"},{"issue":"8","key":"336_CR41","doi-asserted-by":"publisher","first-page":"e020432","DOI":"10.1136\/bmjopen-2017-020432","volume":"8","author":"G Murenzi","year":"2018","unstructured":"Murenzi G, Dusingize JC, Rurangwa T, et al. Protocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda. BMJ Open. 2018;8(8):e020432.","journal-title":"BMJ Open"}],"container-title":["BMC Global and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44263-026-00336-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44263-026-00336-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44263-026-00336-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:20:49Z","timestamp":1792160449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44263-026-00336-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["336"],"URL":"https:\/\/doi.org\/10.1186\/s44263-026-00336-0","relation":{},"ISSN":["2731-913X"],"issn-type":[{"value":"2731-913X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of the PNG Institute of Medical Research (IRB1907), the Medical Research Advisory Committee of the PNG National Department of Health (MRAC19.10), and the Research Advisory Committee of the PNG National AIDS Council (RAC18.009) in PNG; and by the Human Research Ethics Committee, UNSW Sydney, Australia (HC190217). All study participants provided written informed consent to participate. The study was conducted in accordance with ICH Good Clinical Practice (GCP) guidelines and the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"103"}}